Item 8.01 Other Events On November 10, 2026, Conexeu Sciences Inc. (the "Company") filed a Notice of Meeting and Record Date for its Special Meeting of Stockholders to be held on January 26, 2027 on the System for Electronic Document Analysis and Retrieval with the British Columbia Securities Commission in Canada in accordance with the requirements of the Canadian Securities Administrators Nationa…
Filed Nov 16, 2026Accepted Nov 16, 2026, 4:30 PM ESTCIK 2066836Accession 0001062993-26-006086
The Company's proprietary formula, CXUTM, is an ECM scaffold device candidate protected by patents (collectively, the "Patents") in Australia, and the European Union (validated in Belgium, Switzerland, Germany, Spain, France, Great Britain, Ireland, Italy, and the Netherlands), Japan, and the USA, which form a critical barrier to entry and secure our competitive advantage in regenerative medicine. Origin and ownership of the Company's core patent rights were assigned from the University. Patent protection in Canada for such proprietary ECM scaffold technology remains pending. The Patents are summarized in the table below:
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events
On November 10, 2026, Conexeu Sciences Inc. (the "Company") filed a Notice of Meeting and Record Date for its Special Meeting of Stockholders to be held on January 26, 2027 on the System for Electronic Document Analysis and Retrieval with the British Columbia Securities Commission in Canada in accordance with the requirements of the Canadian Securities Administrators National Instrument 54-101 - Communication with Beneficial Owners of Securities of a Reporting Issuer as the Company is a reporting issuer in British Columbia, Canada.
A copy of the Notice of Meeting and Record Date is filed as Exhibit 99.1 hereto.
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS